Genmab A (GMAB) Total Liabilities: 2018-2021
- Genmab A's Total Liabilities fell 8.76% to $264.92 in Q2 2021 from the same period last year, while for Jun 2021 it was $264.92, marking a year-over-year decrease of 8.76%. This contributed to the annual value of $204.5 million for FY2020, which is 104.16% up from last year.
- According to the latest figures from Q2 2021, Genmab A's Total Liabilities is $264.92, which was down 100.00% from $204.5 million recorded in Q4 2020.
- In the past 5 years, Genmab A's Total Liabilities registered a high of $204.5 million during Q4 2020, and its lowest value of $264.92 during Q2 2021.
- For the 3-year period, Genmab A's Total Liabilities averaged around $75.6 million, with its median value being $73.2 million (2019).
- Over the last 5 years, Genmab A's Total Liabilities had its largest YoY gain of 104.16% in 2020, and its largest YoY loss of 100.00% in 2020.
- Over the past 4 years, Genmab A's Total Liabilities (Quarterly) stood at $49.4 million in 2018, then spiked by 102.80% to $100.1 million in 2019, then spiked by 104.16% to $204.5 million in 2020, then decreased by 8.76% to $264.92 in 2021.
- Its Total Liabilities stands at $264.92 for Q2 2021, versus $204.5 million for Q4 2020 and $290.34 for Q2 2020.
